Vasikaran S - Search Results

1

Bone turnover marker monitoring in osteoporosis treatment response.

Tan RZ, Loh TP, Vasikaran S. Tan RZ, et al. Among authors: vasikaran s. Eur J Endocrinol. 2020 Jun 1;183(1):C5-C7. doi: 10.1530/EJE-19-0970. Eur J Endocrinol. 2020. PMID: 32504486 Review. No abstract available.

2

Utility of biochemical markers of bone turnover and bone mineral density in management of osteoporosis.

Vasikaran SD. Vasikaran SD. Crit Rev Clin Lab Sci. 2008;45(2):221-58. doi: 10.1080/10408360801949442. Crit Rev Clin Lab Sci. 2008. PMID: 18415816 Review.

3

Standardising biochemical assessment of bone turnover in osteoporosis.

Vasikaran SD, Morris HA, Cooper C, Kanis JA. Vasikaran SD, et al. Clin Biochem. 2011 Sep;44(13):1033-1034. doi: 10.1016/j.clinbiochem.2011.07.001. Epub 2011 Jul 19. Clin Biochem. 2011. PMID: 21784064 No abstract available.

4

Towards optimising the provision of laboratory services for bone turnover markers.

Vasikaran SD, Chubb SA, Schneider HG. Vasikaran SD, et al. Pathology. 2014 Jun;46(4):267-73. doi: 10.1097/PAT.0000000000000092. Pathology. 2014. PMID: 24798169 Review.

5

The use of biochemical markers of bone turnover in the clinical management of primary and secondary osteoporosis.

Vasikaran SD, Chubb SA. Vasikaran SD, et al. Endocrine. 2016 May;52(2):222-5. doi: 10.1007/s12020-016-0900-2. Epub 2016 Feb 23. Endocrine. 2016. PMID: 26906711

6

Bone turnover markers: Defining a therapeutic target.

Chubb SA, Byrnes E, Manning L, Golledge J, Ebeling PR, Flicker L, Yeap BB, Vasikaran SD. Chubb SA, et al. Among authors: vasikaran sd. Clin Biochem. 2017 Feb;50(3):162-163. doi: 10.1016/j.clinbiochem.2016.09.010. Epub 2016 Sep 13. Clin Biochem. 2017. PMID: 27637294 No abstract available.

7

Assessment of bone turnover in osteoporosis: harmonization of the total testing process.

Vasikaran S. Vasikaran S. Clin Chem Lab Med. 2018 Sep 25;56(10):1603-1607. doi: 10.1515/cclm-2017-1109. Clin Chem Lab Med. 2018. PMID: 29381471 Free article. No abstract available.

8

Clinical utility of bone turnover markers in the management of common metabolic bone diseases in adults.

Glendenning P, Chubb SAP, Vasikaran S. Glendenning P, et al. Among authors: vasikaran s. Clin Chim Acta. 2018 Jun;481:161-170. doi: 10.1016/j.cca.2018.03.009. Epub 2018 Mar 12. Clin Chim Acta. 2018. PMID: 29544749 Review.

9

Interpretative commenting in clinical chemistry with worked examples for thyroid function test reports.

Vasikaran S, Loh TP. Vasikaran S, et al. Pract Lab Med. 2021 Jul 9;26:e00243. doi: 10.1016/j.plabm.2021.e00243. eCollection 2021 Aug. Pract Lab Med. 2021. PMID: 34286057 Free PMC article. Review.

10

Comparison of four indirect (data mining) approaches to derive within-subject biological variation.

Tan RZ, Markus C, Vasikaran S, Loh TP; APFCB Harmonization of Reference Intervals Working Group. Tan RZ, et al. Among authors: vasikaran s. Clin Chem Lab Med. 2022 Feb 3;60(4):636-644. doi: 10.1515/cclm-2021-0442. Print 2022 Mar 28. Clin Chem Lab Med. 2022. PMID: 35107229 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

153 results

Search Page

Filters